Anzeige
Mehr »
Login
Samstag, 28.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Jetzt ist die Zeit, um in unterbewertete Goldaktien mit MEGA-Hebel zu investieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
304 Leser
Artikel bewerten:
(1)

Cowen Inc.: Cowen Announces Financial Results for Full Year 2022

  • Reports 4Q22 GAAP Net Income to common stockholders of $11.2 million, or $0.34 per diluted share
  • Economic Operating Income of $9.6 million, or $0.29 per diluted share (Non-GAAP)

NEW YORK, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ: COWN) ("Cowen" or "the Company") today announced its operating results for the fourth quarter and full year ended December 31, 2022.

Announced Transaction

On August 2, 2022, TD Bank Group ("TD") and Cowen announced a definitive agreement for TD to acquire Cowen in an all-cash transaction valued at approximately $1.3 billion, or $39 for each Class A common share of Cowen. The transaction remains on track to close in the first calendar quarter of 2023 and is subject to customary closing conditions, including receipt of certain regulatory approvals.

Fourth Quarter 2022 Financial Summary

Operating Results
(GAAP)
Economic Operating
Income (Non-GAAP)
Three Months Ended
December 31,
Three Months Ended
December 31,
($ in millions, except per share information) 2022 2021 ? % 2022 2021 ? %
Revenue/Economic Proceeds (Non-GAAP)$413.9 $494.3 (16)% $371.7 $454.0 (18)%
Net income (loss) attributable to common stockholders for diluted earnings per share/Economic Operating Income (Non-GAAP)$11.2 $63.3 (82)% $9.6 $86.7 (89)%
Earnings (loss) per common share (diluted)$0.34 $2.02 (83)% $0.29 $2.77 (90)%
Note: Throughout this press release the Company presents Non-GAAP financial measures that are not prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). A reconciliation of these Non-GAAP measures appears under the section, "Reconciliation of US GAAP (Unaudited) to Non-GAAP Measures."


Capital Optimization Update
During 2022, the Company repurchased $31.1 million of its common stock, or 1,069,002 shares, at an average price of $29.07 per share under the Company's existing share repurchase program. Outside the share repurchase program, the Company acquired approximately $36.1 million of stock as a result of net share settlements relating to the vesting of equity awards, or 1,058,933 shares, at an average price of $34.07 per share.

Quarterly Cash Dividend
On February 14, 2023, the Board of Directors declared a cash dividend of $0.12 per common share. The dividend will be payable on March 15, 2023, to stockholders of record as of the close of trading on March 1, 2023. If the merger with TD is consummated prior to the close of trading on March 1, 2023, no dividend will be paid to stockholders of Cowen who hold common shares prior to the closing of the merger with TD.

Select Balance Sheet Data

(Amounts in millions, except per share information)
December 31, 2022 December 31, 2021
Common equity (CE)$1,064.2 $1,015.9
Book value per share (CE/CSO)$37.69 $36.57
Common shares outstanding (CSO) 28.2 27.8
Note: Common Equity (CE) is equivalent to Cowen Inc. stockholders' equity.



Cowen Inc.
US GAAP Preliminary Unaudited Condensed Consolidated Statements of Operations
(Dollar and share amounts in thousands, except per share data)
Three Months Ended Twelve Months Ended
December 31 December 31
2022 2021 2022 2021
Revenue
Investment banking$138,651 $263,815 $494,842 $1,067,162
Brokerage 133,382 140,994 592,292 585,162
Investment income (loss)
Securities principal transactions, net 31,205 10,282 112,829 122,110
Portfolio fund principal transactions, net 11,365 (2,062) (4,442) 338
Carried interest allocations 8,152 4,291 (31,555) 5,059
Total investment income (loss) 50,722 12,511 76,832 127,507
Management fees 16,529 16,216 66,670 72,287
Incentive income 13 299 646 2,732
Interest and dividends 69,370 51,753 312,134 219,292
Insurance and reinsurance premiums 186 8,435 36,522 39,631
Other revenues, net 14,208 2,599 7,010 5,211
Consolidated Funds revenues (9,134) (2,342) (49,225) (6,185)
Total revenue 413,927 494,280 1,537,723 2,112,799
Interest and dividends expense 82,407 47,638 259,126 211,387
Total net revenue 331,520 446,642 1,278,597 1,901,412
Expenses
Employee compensation and benefits 229,008 237,303 771,386 1,046,371
Insurance and reinsurance claims, commissions and amortization of deferred acquisition costs (35,890) 9,095 (12,260) 33,938
Operating, general, administrative and other expenses 126,243 121,540 424,470 430,250
Depreciation and amortization expense 6,549 5,289 27,725 19,004
Consolidated Funds expenses 19 111 248 630
Total expenses 325,929 373,338 1,211,569 1,530,193
Other income (loss)
Net (losses) gains on other investments 2,143 11,853 9,613 35,494
Bargain purchase gain, net of tax - - - 3,855
Gain/(loss) on debt extinguishment - - - (4,538)
Total other income (loss) 2,143 11,853 9,613 34,811
Income (loss) before income taxes 7,734 85,157 76,641 406,030
Income tax expense/(benefit) (11,487) 25,175 10,786 102,039
Net income (loss) 19,221 59,982 65,855 303,991
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and funds 6,293 (4,999) (10,603) 8,380
Net income (loss) attributable to Cowen Inc. 12,928 64,981 76,458 295,611
Less: Preferred stock dividends 1,698 1,698 6,792 6,792
Net income (loss) attributable to Cowen Inc. common stockholders$ 11,230 $ 63,283 $ 69,666 $ 288,819
Earnings (loss) per share:
Basic$0.40 $2.28 $2.47 $10.42
Diluted$0.34 $2.02 $2.21 $8.85
Weighted average shares used in per share data:
Basic 28,411 27,731 28,183 27,721
Diluted 32,744 31,355 31,544 32,628


U.S. GAAP Financial Measures

Fourth quarter 2022 revenue was $413.9 million versus $494.3 million in the fourth quarter of 2021. Full-year 2022 revenue was $1.54 billion, down from $2.1 billion for full-year 2021. The year-over-year decrease was primarily due to reduced investment banking activity.

Fourth quarter 2022 investment banking revenues decreased $125.2 million to $138.7 million. Full-year 2022 investment banking revenues decreased $572.3 million to $494.8 million. During full-year 2022, the Company completed 49 underwriting transactions and 137 strategic advisory transactions.

Fourth quarter 2022 brokerage revenues decreased $7.6 million to $133.4 million. Full-year 2022 brokerage revenues increased $7.1 million to $592 million. The year-over-year increase was attributable to an increase in institutional services activity.

Fourth quarter 2022 investment income increased $38.2 million to $50.7 million. Full-year 2022 investment income decreased $50.6 million to $76.8 million. The year-over-year decrease is primarily due to negative carried interest allocations.

Fourth quarter 2022 interest and dividends increased $17.6 million to $69.4 million. Full-year 2022 interest and dividends income increased $92.8 million to $312.1 million. The increase in interest and dividends is primarily attributable to dividends receivable.

Fourth quarter 2022 employee compensation and benefits expenses were $229.0 million, a decrease of $8.3 million from the prior-year period. Full-year 2022 employee compensation and benefits expenses decreased $275 million to $771.4 million. The year-over-year decrease was primarily due to lower revenue.

Fourth quarter 2022 total expenses were $325.9 million, a decrease of $47.4 million from the prior-year period. Full-year 2022 total expenses decreased $318.6 million to $1.21 billion. The year-over-year decrease was primarily driven by lower compensation expenses associated with lower revenues.

Fourth quarter 2022 income tax benefit was $11.5 million compared to $25.2 million income tax expense in the prior-year quarter. Full-year 2022 income tax expense decreased $91.2 million to $10.8 million. The decrease was primarily due to the year-over-year decrease in the Company's income before income taxes.

Fourth quarter 2022 net income attributable to common stockholders was $11.2 million, down from $63.3 million in the fourth quarter of 2021. Full-year 2022 net income decreased $219.1 million to $69.7 million.

Non-GAAP Financial Measures

Throughout this press release, the Company presents supplemental financial measures that are not prepared in accordance with US GAAP. These Non-GAAP financial measures include (i) Pre-tax Economic Income (Loss) (ii) Economic Income (Loss), (iii) Economic Operating Income (Loss), (iv) Economic Proceeds and related components, (v) Net Economic Proceeds and related components, (vi) Economic Expenses and related components and (vii) related per share measures. The Company believes that these Non-GAAP financial measures, viewed in addition to, and not in lieu of, the Company's reported US GAAP results, provide useful information to investors and analysts regarding its performance and overall results of operations as it presents investors and analysts with a supplemental operating view of the Company's financials to help better inform their analysis of the Company's performance.

These Non-GAAP financial measures are an integral part of the Company's internal reporting to measure the performance of its business segments, allocate capital and other strategic decisions as well as assess the overall effectiveness of senior management. The Company believes that presenting these Non-GAAP measures may provide expanded transparency into the Company's business operations, growth opportunities and expense allocation decisions.

The Company's primary Non-GAAP financial measures of profit or loss are Pre-tax Economic Income (Loss), Economic Income (Loss) and Economic Operating Income (Loss). Pre-tax Economic Income (Loss) is a pre-tax measure which (i) includes management reclassifications which the Company believes provide additional insight on the performance of the Company's core businesses and divisions; (ii) eliminates the impact of consolidation for Consolidated Funds; and excludes (iii) goodwill and intangible impairment, (iv) certain other transaction-related adjustments and/or reorganization expenses, as well as (v) certain costs associated with debt. Economic Income (Loss) is a similar measure, but after tax, which includes the Company's income tax expense or benefit calculated on Pre-tax Economic Income (Loss) once all currently available net operating losses have been utilized (this occurred during tax year 2020) and is presented after preferred stock dividends. Economic Operating Income (Loss) is a similar measure to Economic Income (Loss), but before depreciation and amortization expenses. The Company believes that these Non-GAAP financial measures provide analysts and investors transparency into the measures of profit and loss management uses to evaluate the financial performance of and make operating decisions for the segments including determining appropriate compensation levels. Additionally, the measures provide investors and analysts with additional insight into the activities of the Company's core businesses, taking into account, among other things, the impact of minority investment stakes, securities borrowing and lending activities and expenses from investment banking activities on US GAAP reported results. The Company presents Pre-tax Economic Income (Loss) in addition to Economic Income (Loss) and Economic Operating Income (Loss) to provide insight to investors and analysts on how the Company manages its tax position over time.

In addition to Pre-tax Economic Income (Loss), Economic Income (Loss) and Economic Operating Income (Loss), the Company also presents Economic Proceeds, Net Economic Proceeds, Economic Expenses, as well as their related components. These measures include management reclassifications and the elimination of the impact of the consolidation for Consolidated funds as described above. These adjustments are meant to provide comparability to our peers as well as to provide investors and analysts with transparency into how the Company manages its operating businesses and how analysts and investors review and analyze the Company's and its peers' similar lines of businesses. For example, among others, within the Company's Op Co business segment, investors and analysts typically review and analyze the performance of investment banking revenues net of underwriting expenses and excluding the impact of reimbursable expenses. Additionally, the performance of the Company's Markets business is typically analyzed as a unit incorporating commissions, interest from securities financing transactions and gains and losses from proprietary and facilitation trading. The Company's investment management business performance is analyzed and reviewed by investors and analysts through investment income, incentive income and management fees. The presentation of Economic Proceeds, Net Economic Proceeds, Economic Expenses as well as their related components align with these and other examples of how the Company's business activities and performance are reviewed by analysts and investors in addition to providing simplification related to legacy businesses and investments for which the Company maintains long-term monetization strategies. Additionally, the Company manages its operating businesses to an Economic Compensation-to-Proceeds ratio. Presentation of Economic Compensation Expense and Economic Proceeds provides transparency in addition to the Company's US GAAP Compensation Expense.

Reconciliations to comparable US GAAP measures are presented along with the Company's Non-GAAP financial measures. The Non-GAAP measures presented herein may not be comparable to similarly titled measures presented by other public companies and are not identical to corresponding measures used in our various agreements or public filings.

These Non-GAAP measures should not be considered in isolation or as a substitute for revenue, expenses, income (loss) before income taxes, net income, operating cash flows, investing and financing activities, or other income or cash flow statement data prepared in accordance with US GAAP. As a result of the adjustments made to arrive at these Non-GAAP measures described below, these Non-GAAP measures have limitations in that they do not take into account certain items included or excluded under US GAAP, including its consolidated funds.

Fourth Quarter and Full Year 2022 Non-GAAP Financial Review

Economic Proceeds

Three Months Ended Twelve Months Ended
December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021
(Dollar amounts in thousands)Op Co Asset
Co
Total Op Co Asset
Co
Total Op Co Asset
Co
Total Op Co Asset
Co
Total
Economic Proceeds
Investment banking$132,371 $- $ 132,371 $255,155 $- $ 255,155 $478,184 $- $ 478,184 $1,025,688 $- $ 1,025,688
Brokerage 167,320 - 167,320 170,347 - 170,347 719,208 - 719,208 728,525 - 728,525
Management fees 19,942 150 20,092 19,807 289 20,096 82,681 850 83,531 79,255 1,200 80,455
Incentive income 13,542 (1,511) 12,031 13,508 (6) 13,502 (12,678) (13,143) (25,821) 34,579 (1,153) 33,426
Investment income (loss) 9,925 (9,292) 633 (8,553) 2,650 (5,903) 21,226 (20,837) 389 8,542 6,014 14,556
Other economic proceeds 39,239 5 39,244 792 (1) 791 57,299 7 57,306 7,942 (2) 7,940
Total: Economic Proceeds 382,339 (10,648) 371,691 451,056 2,932 453,988 1,345,920 (33,123) 1,312,797 1,884,531 6,059 1,890,590
Economic Interest Expense / (Income) 10,563 1,274 11,837 4,879 698 5,577 5,233 283 5,516 23,914 3,779 27,693
Net Economic Proceeds$ 371,776 $ (11,922) $ 359,854 $ 446,177 $ 2,234 $ 448,411 $ 1,340,687 $ (33,406) $ 1,307,281 $ 1,860,617 $ 2,280 $ 1,862,897


Economic Proceeds
were $371.7 million, down 18% from the prior-year period. Full-year 2022 economic proceeds were $1,312.8 million, down 31% year-over-year.

Investment Banking Economic Proceeds were $132.4 million, down 48% from the prior-year period. Full-year 2022 banking proceeds were $478.2 million, down 53% year-over-year. The decrease was primarily due to reduced capital markets activity.

Brokerage Economic Proceeds were $167.3 million, down 2% from the prior-year period. Full-year 2022 brokerage proceeds were $719.2 million, down 1% year-over-year.

Management Fees Economic Proceeds were $20.1 million, flat from the prior-year period. Full-year 2022 management fees were $83.5 million, up 4% year-over-year.

Incentive Income Economic Proceeds were a gain of $12.0 million in the fourth quarter of 2022 versus a gain of $13.5 million in the prior-year period. Full-year 2022 incentive income proceeds were a loss of $25.8 million. The decline was primarily due to a decrease in performance fees.

Investment Income Economic Proceeds were a gain of $0.6 million in the fourth quarter of 2022 versus a loss of $5.9 million in the prior-year period. Full-year 2022 investment income proceeds were $0.4 million, a decrease of $14.2 million year-over-year.

Economic Interest Expense (Income) was an expense of $11.8 million, versus an expense of $5.6 million in the prior-year period. Full-year 2022 interest expense decreased $22.2 million year-over-year. The decrease in expense was primarily due to gains from mark-to-market adjustments on interest rate swaps.

Economic Expenses

Three Months Ended Twelve Months Ended
December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021
(Dollar amounts in thousands)Op Co Asset
Co
Total Op Co Asset
Co
Total Op Co Asset
Co
Total Op Co Asset
Co
Total
Economic Expenses
Compensation & Benefits$230,245 $326 $ 230,571 $246,170 $(7,266) $ 238,904 $772,202 $2,330 $ 774,532 $1,046,730 $3,871 $ 1,050,601
Non-Compensation Expenses 113,429 123 113,552 93,994 174 94,168 412,192 232 412,424 359,577 187 359,764
Depreciation & Amortization 6,544 5 6,549 5,282 7 5,289 27,702 23 27,725 18,982 22 19,004
Non-Controlling Interest 502 - 502 1,142 - 1,142 2,314 - 2,314 5,314 - 5,314
Total: Economic Expenses$ 350,720 $ 454 $ 351,174 $ 346,588 $ (7,085) $ 339,503 $ 1,214,410 $ 2,585 $ 1,216,995 $ 1,430,603 $ 4,080 $ 1,434,683


Economic Compensation Expenses
were $230.6 million, down 3% from prior year period. Full-year 2022 economic compensation expenses were $774.5 million, down 26% year-over-year. Full-year 2022 economic compensation-to-proceeds ratio was 59%.

Economic Fixed Non-Compensation Expenses in the fourth quarter of 2022 were up $1.1 million from the prior-year period at $45.0 million. Full-year 2022 economic fixed non-compensation expenses were $172.0 million, up 7% year-over-year due in part to an increase in headcount as well as investments in infrastructure. The fixed non-compensation-to-economic-proceeds ratio rose from 8.5% in FY'21 to 13.1% in FY'22.

Economic Variable Non-Compensation Expenses were $68.6 million in the fourth quarter of 2022, up from $50.3 million in the fourth quarter of 2021. Full-year 2022 economic variable non-compensation expenses were $240.5 million, an increase of 20% year-over-year due in part to increased client event and entertainment costs and a change in business mix. The variable non-compensation-to-proceeds ratio rose from 10.6% in FY'21 to 18.3% in FY'22.

Economic Depreciation and Amortization Expenses were $6.5 million in the fourth quarter of 2022 compared to $5.3 million in the fourth quarter of 2021. Full-year 2022 economic depreciation and amortization expenses were $27.7 million, an increase of 46% due primarily to expenses associated with the Portico acquisition in late 2021.

Economic Income and Economic Operating Income

Three Months Ended Twelve Months Ended
December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021
(Dollar amounts in thousands)Op Co Asset
Co
Total Op Co Asset
Co
Total Op Co Asset
Co
Total Op Co Asset
Co
Total
Pre-tax Economic Income (Loss)$ 21,056 $ (12,376) $ 8,680 $ 99,589 $ 9,319 $ 108,908 $ 126,277 $ (35,991) $ 90,286 $ 430,014 $ (1,800) $ 428,214
Economic income tax expense 5,474 (3,218) 2,256 22,090 2,489 24,579 32,832 (9,358) 23,474 109,654 (460) 109,194
Preferred stock dividends 1,511 187 1,698 1,477 221 1,698 5,943 849 6,792 5,841 951 6,792
Economic Income (Loss) $ 14,071 $ (9,345) $ 4,726 $ 76,022 $ 6,609 $ 82,631 87,502 (27,482) 60,020 314,519 (2,291) 312,228
Add back: Depreciation and amortization expense, net of taxes 4,843 3 4,846 4,072 5 4,077 20,500 17 20,517 14,142 16 14,158
Economic Operating Income (Loss)$ 18,914 $ (9,342) $ 9,572 $ 80,094 $ 6,614 $ 86,708 $ 108,002 $ (27,465) $ 80,537 $ 328,661 $ (2,275) $ 326,386
Economic Income per diluted share$0.43 $(0.29) $ 0.14 $2.42 $0.21 $ 2.64 $2.77 $(0.87) $ 1.90 $9.64 $(0.07) $ 9.57
Economic Operating Income per diluted share$0.58 $(0.29) $ 0.29 $2.55 $0.21 $ 2.77 $3.42 $(0.87) $ 2.55 $10.07 $(0.07) $ 10.00


The following tables reconciles total US GAAP Revenues and Other Income (Loss) to total Economic Proceeds for the three and twelve months ended December 31, 2022 and 2021:

For the three months ended December 31, 2022
(Dollar amounts in thousands)
Investment Banking Brokerage Investment Income Management Fees Incentive Income Interest and Dividends Reinsurance Premiums Other Revenues, net Consolidated Funds Revenues Other Income (Loss) Total
Total US GAAP Revenues and Other Income (Loss) $138,651 $133,382 $50,722 $16,529 $13 $69,370 $186 $14,208 $(9,134) $2,143 $416,070
Management Presentation Reclassifications:
Underwriting expensesa (1,867) - - - - - - - - - (1,867)
Reimbursable client expensesb (4,413) - - - - - - (234) - - (4,647)
Securities financing interest expensec - (6,783) - - - (19,690) - - - - (26,473)
Fund start-up costs, distribution and other feesd - - - (395) - - - (549) - - (944)
Certain equity method investmentse - - - 3,928 3,866 - - - - (5,763) 2,031
Carried interestf - - (8,152) - 8,152 - - - - - -
Proprietary trading, interest and dividendsg - 4,981 (29,216) - - (44,480) - (10,258) - 29,204 (49,769)
Insurance related activities expensesh - - - - - - (186) 36,077 - - 35,891
Facilitation trading gains and lossesi - 35,740 (6,705) - - (5,200) - - - (25,584) (1,749)
Total Management Presentation Reclassifications: (6,280) 33,938 (44,073) 3,533 12,018 (69,370) (186) 25,036 - (2,143) (47,527)
Fund Consolidated Reclassificationsl - - (6,016) 30 - - - - 9,134 - 3,148
Total Economic Proceeds $132,371 $167,320 $633 $20,092 $12,031 $- $- $39,244 $- $- $ 371,691


For the three months ended December 31, 2021
(Dollar amounts in thousands)
Investment Banking Brokerage Investment Income Management Fees Incentive Income Interest and Dividends Reinsurance Premiums Other Revenues, net Consolidated Funds Revenues Other Income (Loss) Total
Total US GAAP Revenues and Other Income (Loss) $263,815 $140,994 $12,511 $16,216 $299 $51,753 $8,435 $2,599 $(2,342) $11,853 $506,133
Management Presentation Reclassifications:
Underwriting expensesa (4,703) - - - - - - - - - (4,703)
Reimbursable client expensesb (3,957) - - - - - - (234) - - (4,191)
Securities financing interest expensec - (1,126) - - - (32,855) - - - - (33,981)
Fund start-up costs, distribution and other feesd - - - (341) - - - (719) - - (1,060)
Certain equity method investmentse - - - 4,168 9,212 - - - - (10,962) 2,418
Carried interestf - - (4,291) - 4,396 - - - - - 105
Proprietary trading, interest and dividendsg - 9,371 (13,028) - (285) (7,217) - (195) - 12,767 1,413
Insurance related activities expensesh - - - - - - (8,435) (660) - - (9,095)
Facilitation trading gains and lossesi - 21,108 20 - - (11,681) - - - (13,658) (4,211)
Total Management Presentation Reclassifications: (8,660) 29,353 (17,299) 3,827 13,323 (51,753) (8,435) (1,808) - (11,853) (53,305)
Fund Consolidated Reclassificationsl - - (1,115) 53 (120) - - - 2,342 - 1,160
Total Economic Proceeds $255,155 $170,347 $(5,903) $20,096 $13,502 $- $- $791 $- $- $ 453,988


For the twelve months ended December 31, 2022
(Dollar amounts in thousands)
Investment Banking Brokerage Investment Income Management Fees Incentive Income Interest and Dividends Reinsurance Premiums Other Revenues, net Consolidated Funds Revenues Other Income (Loss) Total
Total US GAAP Revenues and Other Income (Loss) $494,842 $592,292 $76,832 $66,670 $646 $312,134 $36,522 $7,010 $(49,225) $9,613 $1,547,336
Management Presentation Reclassifications:
Underwriting expensesa (4,914) - - - - - - - - - (4,914)
Reimbursable client expensesb (11,744) - - - - - - (1,101) - - (12,845)
Securities financing interest expensec - (10,363) - - - (103,924) - - - - (114,287)
Fund start-up costs, distribution and other feesd - - - (1,513) - - - (2,445) - - (3,958)
Certain equity method investmentse - - - 18,208 7,135 - - - - (16,040) 9,303
Carried interestf - - 31,555 - (28,781) - - - - - 2,774
Proprietary trading gains and lossesg - (55,407) (67,956) - (4,821) (98,139) - 5,060 - 92,981 (128,282)
Insurance related activities expensesh - - - - - - (36,522) 48,782 - - 12,260
Facilitation trading gains and lossesi - 192,686 (7,547) - - (110,071) - - - (86,554) (11,486)
Total Management Presentation Reclassifications: (16,658) 126,916 (43,948) 16,695 (26,467) (312,134) (36,522) 50,296 - (9,613) (251,435)
Fund Consolidated Reclassificationsl - - (32,495) 166 - - - - 49,225 - 16,896
Total Economic Proceeds $478,184 $719,208 $389 $83,531 $(25,821) $- $- $57,306 $- $- $ 1,312,797


For the twelve months ended December 31, 2021
(Dollar amounts in thousands)
Investment Banking Brokerage Investment Income Management Fees Incentive Income Interest and Dividends Reinsurance Premiums Other Revenues, net Consolidated Funds Revenues Other Income (Loss) Total
Total US GAAP Revenues and Other Income (Loss) $1,067,162 $585,162 $127,507 $72,287 $2,732 $219,292 $39,631 $5,211 $(6,185) $34,811 $2,147,610
Management Presentation Reclassifications:
Underwriting expensesa (24,978) - - - - - - - - - (24,978)
Reimbursable client expensesb (16,496) - - - - - - (1,206) - - (17,702)
Securities financing interest expensec - 8,006 - - - (153,928) - - - - (145,922)
Fund start-up costs, distribution and other feesd - (361) - (9,190) - - - (2,633) - - (12,184)
Certain equity method investmentse - - - 15,142 25,802 - - - - (32,261) 8,683
Carried interestf - - (5,059) - 5,486 - - - - - 427
Proprietary trading gains and lossesg - 44,241 (92,900) - (494) (19,233) - 875 - 46,918 (20,593)
Insurance related activities expensesh - - - - - - (39,631) 5,693 - - (33,938)
Facilitation trading gains and lossesi - 91,477 (11,034) - - (46,131) - - - (50,151) (15,839)
Total Management Presentation Reclassifications: (41,474) 143,363 (108,993) 5,952 30,794 (219,292) (39,631) 2,729 - (35,494) (262,046)
Fund Consolidated Reclassificationsl - - (3,958) 2,216 (100) - - - 6,185 - 4,343
Income Statement Adjustments
Bargain purchase gainn - - - - - - - - - (3,855) (3,855)
Debt extinguishmentp - - - - - - - - - 4,538 4,538
Total Income Statement Adjustments: - - - - - - - - - 683 683
Total Economic Proceeds $1,025,688 $728,525 $14,556 $80,455 $33,426 $- $- $7,940 $- $- $ 1,890,590


The following table reconciles total US GAAP interest and dividends expense to total Economic Interest Expense for the three and twelve months ended December 31, 2022 and 2021:

Three Months Ended December 31, Twelve Months Ended December 31,
(Dollar amounts in thousands) 2022 2021 2022 2021
Total US GAAP Interest & Dividend Expense $82,407 $47,638 $259,126 $211,387
Management Presentation Reclassifications:
Securities financing interest expensec (26,473) (33,981) (114,287) (145,922)
Fund start-up costs, distribution and other feesd (867) - (3,204) (2,257)
Proprietary trading gains and lossesg (41,402) (3,837) (124,324) (12,515)
Facilitation trading gains and lossesi (1,749) (4,211) (11,486) (15,839)
Total Management Presentation Reclassifications: (70,491) (42,029) (253,301) (176,533)
Income Statement Adjustments:
Accelerated debt costsp - - - (5,557)
Amortization of discount/(premium) on debtm (79) (32) (309) (1,604)
Total Income Statement Adjustments: (79) (32) (309) (7,161)
Total Economic Interest Expense / (Income)$ 11,837 $ 5,577 $ 5,516 $ 27,693


The following tables reconcile total US GAAP Expenses and non-controlling interests to total Economic Expenses for the three and twelve months ended December 31, 2022 and 2021:

Three Months Ended December 31, 2022 Three Months Ended December 31, 2021
(Dollar amounts in thousands) Employee Compensation and Benefits Non-compensation US GAAP Expenses (including Depreciation and Amortization) Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds Total Employee Compensation and Benefits Non-compensation US GAAP Expenses (including Depreciation and Amortization) Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds Total
Total US GAAP $229,008 $96,921 $6,293 $332,222 $237,303 $136,035 $(4,999) $368,339
Management Presentation Reclassifications:
Underwriting expensesa - (1,867) - (1,867) - (4,703) - (4,703)
Reimbursable client expensesb - (4,647) - (4,647) - (4,191) - (4,191)
Fund start-up costs, distribution and other feesd - (77) - (77) - (1,060) - (1,060)
Certain equity method investmentse - 2,031 - 2,031 - 2,418 - 2,418
Carried interestf - - - - - 105 - 105
Proprietary trading gains and lossesg - 1,093 (9,460) (8,367) - 1,522 3,728 5,250
Insurance related activities expensesh - 35,891 - 35,891 - (9,095) - (9,095)
Associated partner/banker compensationj 1,884 (1,884) - - 1,949 (1,949) - -
Management company non-controlling interestk (321) (181) 502 - (348) (794) 1,142 -
Total Management Presentation Reclassifications: 1,563 30,359 (8,958) 22,964 1,601 (17,747) 4,870 (11,276)
Fund Consolidated Reclassificationsl - (19) 3,167 3,148 - (111) 1,271 1,160
Income Statement Adjustments:
Acquisition related adjustmentsn - (8,442) - (8,442) - (5,271) - (5,271)
Contingent liability adjustmentsn - 1,282 - 1,282 - (12,440) - (12,440)
Goodwill and/or other impairmentr - - - - - (1,009) - (1,009)
Total Income Statement Adjustments: - (7,160) - (7,160) - (18,720) - (18,720)
Total Economic Expenses $230,571 $120,101 $502 $ 351,174 $238,904 $99,457 $1,142 $ 339,503


Twelve months Ended December 31, 2022 Twelve months Ended December 31, 2021
(Dollar amounts in thousands) Employee Compensation and Benefits Non-compensation US GAAP Expenses (including Depreciation and Amortization) Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds Total Employee Compensation and Benefits Non-compensation US GAAP Expenses (including Depreciation and Amortization) Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds Total
Total US GAAP $771,386 $440,183 $(10,603) $1,200,966 $1,046,371 $483,822 $8,380 $1,538,573
Management Presentation Reclassifications:
Underwriting expensesa - (4,914) - (4,914) - (24,978) - (24,978)
Reimbursable client expensesb - (12,845) - (12,845) - (17,702) - (17,702)
Fund start-up costs, distribution and other feesd - (754) - (754) - (9,927) - (9,927)
Certain equity method investmentse - 9,303 - 9,303 - 8,683 - 8,683
Carried interestf - 2,774 - 2,774 - 427 - 427
Proprietary trading gains and lossesg - 2,583 (6,541) (3,958) - 5,275 (13,353) (8,078)
Insurance related activities expensesh - 12,260 - 12,260 - (33,938) - (33,938)
Associated partner/banker compensationj 4,509 (4,509) - - 5,621 (5,621) - -
Management company non-controlling interestk (1,363) (951) 2,314 - (1,391) (3,923) 5,314 -
Total Management Presentation Reclassifications: 3,146 2,947 (4,227) 1,866 4,230 (81,704) (8,039) (85,513)
Fund Consolidated Reclassificationsl - (248) 17,144 16,896 - (630) 4,973 4,343
Income Statement Adjustments:
Acquisition related amountsn - (16,293) - (16,293) - (6,593) - (6,593)
Contingent liability adjustmentsn - 13,560 - 13,560 - (15,118) - (15,118)
Goodwill and/or other impairmentr - - - - - (1,009) - (1,009)
Total Income Statement Adjustments: - (2,733) - (2,733) - (22,720) - (22,720)
Total Economic Expenses $774,532 $440,149 $2,314 $ 1,216,995 $1,050,601 $378,768 $5,314 $ 1,434,683


The following table reconciles US GAAP Net Income (loss) Attributable to Cowen Inc. Common Stockholders to Pre-tax Economic Income (Loss), Economic Income (loss) and Economic Operating Income (loss):

Three Months Ended December 31, Twelve Months Ended December 31,
(Dollar amounts in thousands) 2022 2021 2022 2021
US GAAP Net income (loss) attributable to Cowen Inc. common stockholders $ 11,230 $ 63,283 $ 69,666 $ 288,819
Income Statement Adjustments:
US GAAP Income tax expense (benefit)o (11,487) 25,175 10,786 102,039
Amortization of discount (premium) on debtm 79 32 309 1,604
Goodwill and/or other impairmentr - 1,009 - 1,009
Debt extinguishment gain (loss) and/or accelerated debt costsp - - - 10,095
Bargain purchase gainn - - - (3,855)
Contingent liability adjustmentsn (1,282) 12,440 (13,560) 15,118
Acquisition related amountsn 8,442 5,271 16,293 6,593
Preferred stock dividendsq 1,698 1,698 6,792 6,792
Pre-tax Economic Income (Loss) 8,680 108,908 90,286 428,214
Economic income tax expense (2,256) (24,579) (23,474) (109,194)
Preferred stock dividends (1,698) (1,698) (6,792) (6,792)
Economic Income (Loss) 4,726 82,631 60,020 312,228
Add back: Depreciation and amortization expense, net of taxes 4,846 4,077 20,517 14,158
Economic Operating Income (Loss) $ 9,572 $ 86,708 $ 80,537 $ 326,386


The following table reconciles US GAAP Net Income (loss) Attributable to Cowen Inc. Common Stockholders Earnings Per Common Share (Diluted) to Pre-tax Economic Income (loss) Per Common Share (Diluted), Economic Income (loss) Per Common Share (Diluted) and Economic Operating Income (loss) Per Common Share (Diluted):

Three Months Ended December 31, Twelve Months Ended December 31,
(Dollars per share) 2022 2021 2022 2021
US GAAP Net income (loss) attributable to Cowen Inc. common stockholders $ 0.34 $ 2.02 $ 2.21 $ 8.85
Income Statement Adjustments:
US GAAP Income tax expense (benefit)o (0.35) 0.80 0.34 3.13
Amortization of discount (premium) on debtm - - 0.01 0.05
Goodwill and/or other impairmentr - 0.03 - 0.03
Debt extinguishment gain (loss) and accelerated debt costsp - - - 0.31
Bargain purchase gainn - - - (0.12)
Contingent liability adjustmentsn (0.04) 0.40 (0.43) 0.46
Acquisition related amountsn 0.26 0.17 0.52 0.20
Preferred stock dividendsq 0.05 0.05 0.22 0.21
Pre-tax Economic Income (Loss) per common share (diluted) 0.27 3.47 2.86 13.12
Economic income tax expense (0.07) (0.78) (0.74) (3.35)
Preferred stock dividends (0.05) (0.05) (0.22) (0.21)
Economic income (Loss) per common share (diluted) 0.14 2.64 1.90 9.57
Add back: Depreciation and amortization expense, net of taxes 0.15 0.13 0.65 0.44
Economic Operating Income (Loss) per common share (diluted) $ 0.29 $ 2.77 $ 2.55 $ 10.01

Note: Amounts may not add due to rounding.


Adjustments made to US GAAP Net Income (Loss) to arrive at Economic Operating Income (Loss)

Management Reclassifications
Management reclassification adjustments and fund consolidation reclassification adjustments have no effect on Economic Operating Income (Loss). These adjustments are reclassifications to change the location of certain line items.
aUnderwriting expenses: Economic Proceeds presents investment banking revenues net of underwriting expenses.
bReimbursable client expenses: Economic Proceeds presents expenses reimbursed from clients and affiliates within their respective expense category but is included as a part of revenues under US GAAP.
cSecurities financing interest expense: Brokerage within Economic Proceeds included net securities borrowed and securities loaned activities which are shown gross in interest income and interest expense for US GAAP.
dFund start-up costs, distribution and other fees: Economic Proceeds and Economic Interest Expense are net of fund start-up costs and distribution fees paid to agents and other debt service costs.
eCertain equity method investments: Economic Proceeds and Economic Expenses recognize the Company's proportionate share of management and incentive fees and associated share of expenses on a gross basis for equity method investments within the activist business, real estate operating entities and the healthcare royalty business. The Company applies the equity method of accounting to these entities and accordingly the results from these businesses are recorded within Other Income (Loss) for US GAAP.
fCarried interest: The Company applies an equity ownership model to carried interest which is recorded in Investment income - Carried interest allocation for US GAAP. The Company presents carried interest as Incentive Income Economic Proceeds.
gProprietary trading, interest and dividends: Economic Proceeds presents interest and dividends from the Company's proprietary trading in investment income.
hInsurance related activities expenses: Economic Proceeds presents underwriting income from the Company's insurance and reinsurance related activities, net of expenses, within other revenue. The costs are recorded within expenses for US GAAP reporting.
iFacilitation trading gains and losses: Economic Brokerage Proceeds presents gains and losses on investments held as part of the Company's facilitation and trading business within brokerage revenues as these investments are directly related to the markets business activities while these are presented in Investment income - Securities principal transactions, net for US GAAP reporting.
jAssociated partner/banker compensation reclassification: Economic Compensation Expense presents certain payments to associated banking partners as compensation rather than non-compensation expenses.
kManagement company non-controlling interest: Economic Expenses non-controlling interest represents only operating entities that are not wholly owned by the Company. The Company also presents non-controlling interests within total expenses for Economic Income (Loss).
Fund Consolidation Reclassifications
lThe impacts of consolidation and the related elimination entries of the Consolidated Funds are not included in Economic Income (Loss). Adjustments to reconcile to US GAAP Net Income (Loss) included elimination of incentive income and management fees earned from the Consolidated Funds and addition of investment fund expenses excluding management fees paid, investment fund revenues and investment income (loss).
Income Statement Adjustments
mPre-tax Economic Income (Loss) excludes the amortization of discount (premium) on debt.
nPre-tax Economic Income (Loss) excludes acquisition related adjustments (including bargain purchase gain and contingent liability adjustments).
oPre-tax Economic Income (Loss) excludes US GAAP income taxes.
pPre-tax Economic Income (Loss) excludes gain/(loss) on debt extinguishment and accelerated debt costs.
qPre-tax Economic income (Loss) excludes preferred stock dividends.
rEconomic Income (Loss) excludes goodwill and other impairments.


About Cowen Inc.
Cowen Inc. ("Cowen" or the "Company") is a diversified financial services firm that provides investment banking, research, sales and trading, prime brokerage, outsourced trading and commission management services. Cowen also has an investment management division which offers actively managed alternative investment products. Founded in 1918, the Company is headquartered in New York and has offices worldwide. Learn more at Cowen.com

Investor Relations Contact:
Steve Lasota, Chief Financial Officer
(646) 662-2778
stephen.lasota@cowen.com

Source: Cowen Inc.


Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements include statements about the Company's expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. As a result of the spread of COVID-19, economic uncertainties have arisen that have the potential in future periods to negatively impact the Company's business, financial condition, results of operation, cash flows, strategies and prospects. The extent of the impact of COVID-19 on the Company's operational and financial performance will depend on certain developments, including the duration and spread of the outbreak and impact on our clients, employees, vendors and the markets in which we operate our businesses, all of which are uncertain and cannot be reasonably estimated at this time. The Company's actual results could differ materially from those anticipated in forward-looking statements for many reasons, including the factors described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. The Annual Report on Form 10-K and Quarterly Reports on Form 10-Q are available at our website at www.cowen.com and at the Securities and Exchange Commission website at www.sec.gov. Unless required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect circumstances or events after the date of this press release.


© 2023 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.